| Followers | 843 |
| Posts | 122881 |
| Boards Moderated | 9 |
| Alias Born | 09/05/2002 |
Thursday, March 19, 2020 10:05:08 AM
https://finance.yahoo.com/news/abbott-receives-fda-emergency-authorization-220000633.html
As a leader in diagnostics testing, Abbott is working to do its part to combat this global pandemic. Across the U.S., more than 175 m2000 systems are used in hospital and reference laboratories. The systems have the ability to run high volumes of up to 470 tests in 24 hours, helping to meet the increasing demand for testing. Many of these instruments are used in university and community hospitals where patients come for care, resulting in testing that happens closer to the patient rather than sending it to an offsite lab.
Abbott is immediately distributing 150,000 tests and will continue ramping up production to the highest levels possible, with the goal of providing up to 1 million tests per week. Abbott is manufacturing these tests in the U.S.
“The efficient-market hypothesis may be
the foremost piece of B.S. ever promulgated
in any area of human knowledge!”
Recent ABT News
- Form 8-K - Current report • Edgar (US Regulatory) • 04/17/2026 08:04:06 PM
- New data at AACR 2026 demonstrate advancements in Cancerguard® Multi-Cancer Early Detection Test • PR Newswire (US) • 04/17/2026 07:30:00 PM
- Abbott Shares Slip on Weaker Q2 Outlook Despite In-Line Q1 Results • IH Market News • 04/16/2026 02:13:53 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 04/16/2026 11:36:25 AM
- Abbott Reports First-Quarter 2026 Results; Updates Guidance to Reflect Acquisition of Exact Sciences • PR Newswire (US) • 04/16/2026 11:30:00 AM
- New survey finds most Americans believe chronic diseases are preventable, but only 1 in 4 feel confident in how to care for their health • PR Newswire (US) • 04/09/2026 01:00:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 04/02/2026 09:31:52 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 04/02/2026 09:24:18 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 04/02/2026 09:15:44 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 04/02/2026 09:07:24 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 04/02/2026 09:00:50 PM
- Abbott expands access to Precision Oncology portfolio through integration with Flatiron's OncoEMR® platform • PR Newswire (US) • 03/30/2026 01:00:00 PM
- Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend] • Edgar (US Regulatory) • 03/26/2026 07:05:51 PM
- Abbott hosts conference call for first-quarter earnings • PR Newswire (US) • 03/26/2026 01:00:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/25/2026 10:56:57 PM
- Form 3 - Initial statement of beneficial ownership of securities • Edgar (US Regulatory) • 03/25/2026 10:46:39 PM
- John Stamos and Jodie Sweetin reunite for "The (Second) Talk" with Cologuard® tests, encouraging colon cancer screening • PR Newswire (US) • 03/24/2026 12:00:00 PM
- Form S-8 - Securities to be offered to employees in employee benefit plans • Edgar (US Regulatory) • 03/23/2026 09:30:42 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 03/23/2026 12:54:17 PM
- Abbott completes acquisition of Exact Sciences • PR Newswire (US) • 03/23/2026 12:50:00 PM
- Abbott acquisition of Exact Sciences set to close on March 23, 2026 • PR Newswire (US) • 03/20/2026 01:00:00 PM
- Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material • Edgar (US Regulatory) • 03/13/2026 08:01:21 PM
- Form DEF 14A - Other definitive proxy statements • Edgar (US Regulatory) • 03/13/2026 08:00:23 PM
- Landmark study shows Libre technology helps people with Type 2 diabetes on basal insulin improve glucose management • PR Newswire (US) • 03/12/2026 12:00:00 PM
